Inhibikase Therapeutics Announces Participation in Upcoming Investor Conferences During November 2026GlobeNewswire Oct 27, 2026, 12:00:00 PM
Inhibikase Therapeutics Appoints Scott Wasserman to Board of DirectorsGlobeNewswire Oct 20, 2026, 8:01:00 PM
Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire Oct 2, 2026, 8:01:00 PM
Inhibikase Shares Climb After Revised Drug Timeline, Public OfferingGlobal News Select Nov 21, 2025, 12:08:00 PM